{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:01Z","timestamp":1791097141414,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1086\/374557","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T14:21:09Z","timestamp":1058970069000},"page":"1122-1131","source":"Crossref","is-referenced-by-count":564,"title":["Voriconazole Treatment for Less\u2010Common, Emerging, or Refractory Fungal Infections"],"prefix":"10.1093","volume":"36","author":[{"given":"John R.","family":"Perfect","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"DuPont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"de la Torre\u2010Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Just\u2010Nubling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haran T","family":"Schlamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irja","family":"Lutsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Espinel\u2010Ingroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"rf1_137","doi-asserted-by":"publisher","DOI":"10.1086\/324620"},{"key":"rf2_138","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-5931(97)80007-5"},{"key":"rf3_139","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200203000-00015"},{"key":"rf4_140","first-page":"2227","volume":"12","author":"Hegener P","year":"1998","journal-title":"AIDS"},{"key":"rf5_141","doi-asserted-by":"publisher","DOI":"10.1086\/322653"},{"key":"rf6_142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200201243460403"},{"key":"rf7_143","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200017050-00002"},{"key":"rf8_144","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191"},{"key":"rf9_145","unstructured":"Schoniger S, Hildebrand A, Richer A. Invasive pulmonary aspergillosis refractory to amphotericin B in a patient with persisting neutropenia: successful treatment with voriconazole [abstract P744]. In: Programs and abstracts of the 9th European Congress of Clinical Microbiology and Infectious Diseases (Berlin). 1999."},{"key":"rf10_146","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2000.020307.x"},{"key":"rf11_147","unstructured":"Hoepelman AM, Hodges MR, Lutsar I. Cerebral aspergillosis and scedosporiosis: a new treatment option for children with life threatening cerebral fungal infection [abstract]. In: Programs and abstracts of the 18th European Society for Pediatric Infectious Diseases (Noordwijk, The Netherlands). 2000."},{"key":"rf12_148","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.972911.x"},{"key":"rf13_149","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/517646","volume":"26","author":"de Sevaux RG","year":"1998","journal-title":"Clin Infect Dis"},{"key":"rf14_150","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1164\/ajrccm.157.5.9709068","volume":"157","author":"van\u2019t Hek LGFM","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"rf15_151","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.8.928d"},{"key":"rf16_152","doi-asserted-by":"publisher","DOI":"10.1086\/317496"},{"key":"rf17_153","unstructured":"Torre-Cisneros J, Gonzalez-Ruiz A, Hodges MR, Lutsar I. Voriconazole (VORI) for the treatment of S. apiospermum and S. prolificans infection [abstract 305]. In: Programs and abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America (New Orleans). Alexandria, VA: Infectious Diseases Society of America, 2000."},{"key":"rf18_154","doi-asserted-by":"publisher","DOI":"10.1086\/314042"},{"key":"rf19_155","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/JCM.36.5.1436-1438.1998","volume":"36","author":"Girmenia C","year":"1998","journal-title":"J Clin Microbiol"},{"key":"rf20_156","doi-asserted-by":"publisher","DOI":"10.1080\/00365540050166063"},{"key":"rf21_157","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010954803886"},{"key":"rf22_158","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.3.954-958.2001"},{"key":"rf23_159","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","volume":"36","author":"Espinel-Ingroff A","year":"1998","journal-title":"J Clin Microbiol"},{"key":"rf24_160","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution susceptibility testing of yeasts. Approved standard M27-A. Wayne, PA: NCCLS, 1997."},{"key":"rf25_161","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/JCM.35.1.139-143.1997","volume":"35","author":"Espinel-Ingroff A","year":"1997","journal-title":"J Clin Microbiol"},{"key":"rf26_162","doi-asserted-by":"crossref","unstructured":"Collett D. Modeling survival data in medical research. New York: Chapman & Hall, 1994.","DOI":"10.1007\/978-1-4899-3115-3"},{"key":"rf27_163","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","volume":"26","author":"Walsh TJ","year":"1998","journal-title":"Clin Infect Dis"},{"key":"rf28_164","unstructured":"Maertens J, Road I, Sable CA. Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B and amphotericin B lipid formulations [abstract 371]. In: Programs and abstracts of the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2000."},{"key":"rf29_165","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","volume":"12","author":"Denning DW","year":"1990","journal-title":"Rev Infect Dis"},{"key":"rf30_166","doi-asserted-by":"publisher","DOI":"10.1086\/318483"},{"key":"rf31_167","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200007000-00006"},{"key":"rf32_168","doi-asserted-by":"publisher","DOI":"10.1086\/323900"},{"key":"rf33_169","first-page":"351","volume":"15","author":"Wingard JR","year":"2001","journal-title":"Oncology"},{"key":"rf34_170","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.140409.x"},{"key":"rf35_171","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.2000.tb00004.x"},{"key":"rf36_172","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411173312001"},{"key":"rf37_173","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000239591","volume":"43","author":"Krcmery V","year":"1997","journal-title":"Chemotherapy"},{"key":"rf38_174","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010402.x"},{"key":"rf39_175","doi-asserted-by":"publisher","DOI":"10.1086\/339202"},{"key":"rf40_176","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/JCM.37.4.1186-1189.1999","volume":"37","author":"Verweij PE","year":"1999","journal-title":"J Clin Microbiol"},{"key":"rf41_177","doi-asserted-by":"publisher","DOI":"10.1086\/343746"},{"key":"rf42_178","unstructured":"Tan KKC, Brayshaw N, Oaks M. Investigation of the relationship between plasma voriconazole concentrations and liver function test abnormalities in therapeutic trials [abstract A-18]. In: Programs and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/36\/9\/1122\/885648\/36-9-1122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T16:27:03Z","timestamp":1585067223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/374557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1086\/374557"],"URL":"https:\/\/doi.org\/10.1086\/374557","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}